Company · Boucherville, Quebec, Canada
Altamed Pharma
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 48
- 25 authorized now
- Natural health products
- 31
- 31 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 34
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| ALTA-DULOXETINE | 02481952 | Marketed | |
| ALTA-DULOXETINE | 02481960 | Marketed | |
| ALTA-PANTOPRAZOLE | 02469138 | Marketed | |
| ALTA-ZOPICLONE | 02468492 | Marketed | |
| ALTA-ZOPICLONE | 02469154 | Marketed | |
| AMLODIPINE | 02490781 | Marketed | |
| AMLODIPINE | 02490803 | Marketed | |
| AMLODIPINE | 02490811 | Marketed | |
| PAROXETINE | 02477823 | Marketed | |
| PAROXETINE | 02477831 | Marketed | |
| PAROXETINE | 02477858 | Marketed | |
| PREGABALIN | 02474352 | Marketed | |
| PREGABALIN | 02474360 | Marketed | |
| PREGABALIN | 02474379 | Marketed | |
| PREGABALIN | 02474387 | Marketed | |
| SERTRALINE | 02537249 | Marketed | |
| SERTRALINE | 02537265 | Marketed | |
| SERTRALINE | 02537281 | Marketed | |
| SILDENAFIL | 02537737 | Marketed | |
| ALTA-AZITHROMYCIN | 02477610 | Approved | |
| ALTA-CLOPIDOGREL | 02570491 | Approved | |
| ALTA-CLOPIDOGREL | 02570505 | Approved | |
| ALTA-PERINDOPRIL | 02568608 | Approved | |
| ALTA-PERINDOPRIL | 02568616 | Approved | |
| ALTA-PERINDOPRIL | 02568624 | Approved | |
| ALTA-DOCUSATE SODIUM | 02465329 | Cancelled Post Market | |
| ASA 80MG | 02497115 | Cancelled Post Market | |
| ATORVASTATIN | 02476940 | Cancelled Post Market | |
| ATORVASTATIN | 02476959 | Cancelled Post Market | |
| ATORVASTATIN | 02476967 | Cancelled Post Market | |
| ATORVASTATIN | 02476975 | Cancelled Pre Market | |
| AZITHROMYCIN | 02477629 | Cancelled Pre Market | |
| CELECOXIB | 02477661 | Cancelled Post Market | |
| CELECOXIB | 02477688 | Cancelled Post Market | |
| ESCITALOPRAM | 02506602 | Cancelled Pre Market | |
| ESCITALOPRAM | 02506610 | Cancelled Pre Market | |
| ESCITALOPRAM | 02506629 | Cancelled Pre Market | |
| ESCITALOPRAM | 02506637 | Cancelled Pre Market | |
| FLUOXETINE | 02490595 | Cancelled Post Market | |
| FLUOXETINE | 02490609 | Cancelled Post Market | |
| OMEPRAZOLE | 02490692 | Cancelled Post Market | |
| RAMIPRIL | 02486504 | Cancelled Pre Market | |
| RAMIPRIL | 02486512 | Cancelled Post Market | |
| RAMIPRIL | 02486520 | Cancelled Post Market | |
| RAMIPRIL | 02486539 | Cancelled Post Market | |
| RAMIPRIL | 02486547 | Cancelled Pre Market | |
| SILDENAFIL | 02537710 | Cancelled Pre Market | |
| SILDENAFIL | 02537729 | Cancelled Pre Market |
Natural health products
Active licences first, newest first.
Notices of Compliance
Newest first.
- ALTA-ZOPICLONEJuly 29, 2026 · NOC 38016 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ALTA-CLOPIDOGRELJuly 20, 2026 · NOC 38020 · Abbreviated New Drug Submission (ANDS)
- ALTA-DULOXETINEJune 12, 2026 · NOC 37706 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ALTA-AZITHROMYCINMay 26, 2026 · NOC 37622 · Abbreviated New Drug Submission (ANDS)
- ALTA-PERINDOPRILMay 26, 2026 · NOC 37633 · Abbreviated New Drug Submission (ANDS)
- ALTA-PANTOPRAZOLENovember 11, 2025 · NOC 36354 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ZOPICLONEOctober 21, 2025 · NOC 36216 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PREGABALINApril 9, 2025 · NOC 35149 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PANTOPRAZOLEApril 9, 2025 · NOC 35151 · Supplement to an Abbreviated New Drug Submission (SANDS)
- DULOXETINENovember 25, 2024 · NOC 34441 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SILDENAFILNovember 15, 2024 · NOC 34399 · Supplement to an Abbreviated New Drug Submission (SANDS)
- PAROXETINEOctober 1, 2024 · NOC 34117 · Supplement to an Abbreviated New Drug Submission (SANDS)
- FLUOXETINESeptember 27, 2024 · NOC 34118 · Supplement to an Abbreviated New Drug Submission (SANDS)
- SERTRALINEJuly 29, 2024 · NOC 33727 · Supplement to an Abbreviated New Drug Submission (SANDS)
- AMLODIPINEJuly 16, 2024 · NOC 33656 · Abbreviated New Drug Submission (ANDS)
- SILDENAFILMay 3, 2023 · NOC 30641 · Abbreviated New Drug Submission (ANDS)
- SERTRALINEApril 20, 2023 · NOC 30604 · Abbreviated New Drug Submission (ANDS)
- DULOXETINEFebruary 6, 2023 · NOC 30067 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ZOPICLONEJanuary 5, 2023 · NOC 29855 · Supplement to an Abbreviated New Drug Submission (SANDS)
- ESCITALOPRAMOctober 19, 2020 · NOC 24459 · Abbreviated New Drug Submission (ANDS)
- AMLODIPINEJuly 23, 2019 · NOC 22440 · Abbreviated New Drug Submission (ANDS)
- OMEPRAZOLEJuly 19, 2019 · NOC 22423 · Abbreviated New Drug Submission (ANDS)
- FLUOXETINEJuly 17, 2019 · NOC 22411 · Abbreviated New Drug Submission (ANDS)
- PANTOPRAZOLEMarch 15, 2019 · NOC 21982 · Supplement to an Abbreviated New Drug Submission (SANDS)
- RAMIPRILMarch 12, 2019 · NOC 21960 · Abbreviated New Drug Submission (ANDS)
- DULOXETINEOctober 29, 2018 · NOC 21472 · Abbreviated New Drug Submission (ANDS)
- AZITHROMYCINJune 27, 2018 · NOC 21028 · Abbreviated New Drug Submission (ANDS)
- CELECOXIBJune 27, 2018 · NOC 21029 · Abbreviated New Drug Submission (ANDS)
- PAROXETINEJune 27, 2018 · NOC 21030 · Abbreviated New Drug Submission (ANDS)
- ATORVASTATINJune 5, 2018 · NOC 20944 · Abbreviated New Drug Submission (ANDS)
- PREGABALINApril 10, 2018 · NOC 20723 · Abbreviated New Drug Submission (ANDS)
- TRAMADOL/ACETNovember 8, 2017 · NOC 20017 · Abbreviated New Drug Submission (ANDS)
- ZOPICLONEOctober 30, 2017 · NOC 19976 · Abbreviated New Drug Submission (ANDS)
- PANTOPRAZOLEOctober 25, 2017 · NOC 19956 · Abbreviated New Drug Submission (ANDS)